References
- Braga RCO. Relatório dos Comitês de Morte Materna no Paraná. Femina 1993;21:794–811
- GiVord RW. Report of the national high blood pressure education program working group on high blood pressure in pregnancy. Am J Obstet Gynecol 2000;183:S.1–22
- Zhou Y, McMaster M, Woo K, et al. Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am J Pathol 2002;160:1405–23
- Corrêa RRM, Gilio DB, Cavellani CL, et al. Placental morphometrical and histopathology changes in the diVerent clinical presentations of hypertensive syndromes in pregnancy. Arch Gynecol Obstet 2008;277:201–6
- Lorquet S, Pequeux C, Munaut C, Foidart JM. Aetiology and physiopathology of preeclampsia and related forms. Acta Clin Belg 2010;65:237–41
- Gitto E, Karbownik M, Reiter RJ, et al. Effects of melatonin treatment in septic newborns. Pediatr Res 2001;50:756–60
- Corrêa RR, Barrilari SE, Guimarães CS, et al. Expression of the melatonin receptor and tryptophan hydroxylase in placentas of the fetus with intra-uterine stress. Eur J Obstet Gynecol Reprod Biol 2009;147:234–6
- Paulis L, Pechanova O, Zicha J, et al. Melatonin interactions with blood pressure and vascular function during l-NAME-induced hypertension. J Pineal Res 2010;48:102–8
- Gifford RW. Report of the national high blood pressure education program working group on high blood pressure in pregnancy. Am J Obstet Gynecol 2000;183:S.1–22
- Whitehead AN. Sample size. In: Motulsky H, ed. Intuitive biostatistics. Oxford University Press; 2010:87–95
- Gratton RJ, Gluszynski M, Nygard K, et al. Reducing agent and tunicamycin-responsive protein (RTP) mRNA expression in the placentae of normal and pre-eclamptic women. Placenta 2004;25:62–9
- Aversa S, Pellegrino S, Barberi I, et al. Potential utility of melatonin as an antioxidant during pregnancy and in the perinatal period. J Matern Fetal Neonatal Med 2011;May 11
- Lanoix D, Beghdadi H, Lafond J, Vaillancourt C. Human placental trophoblasts synthesize melatonin and express its receptors. J Pineal Res 2008;45:50–60
- Olegário JG, Silva MV, Machado JR, et al. Pulmonary innate immune response and melatonin receptors in the perinatal stress. Clin Dev Immunol 2013. [Epub ahead of print]. doi:10.1155/2013/340959
- Kort DH, Gosselin J, Choi JM, et al. Pregnancy after age 50: defining risks for mother and child. Am J Perinatol 2012;29:245–50
- Richter HG, Hansell JA, Raut S, Giussani DA. Melatonin improves placental efficiency and birth weight and increases the placental expression of antioxidant enzymes in undernourished pregnancy. J Pineal Res 2009;46:357–64
- Shuaib AA, Frass KA, Al-Harazi AH, Ghanem NS. Pregnancy outcomes of mothers aged 17 years or less. Saudi Med J 2011;32:166–70
- Fox, H. The significance of villous syncytial knots in the human placenta. J Obstet Gynaecol Br Commonw 1965;72:347–55
- Taché V, Lacoursiere DY, Saleemuddin A, Parast MM. Placental expression of vascular endothelial growth factor receptor-1/soluble vascular endothelial growth factor receptor-1 correlates with severity of clinical preeclampsia and villous hypermaturity. Hum Pathol 2011;42:1283–8